Institute of Clinical Neurobiology, University Hospital Würzburg, Würzburg, Germany.
Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany; Core Unit SysMed, University of Würzburg, Würzburg, Germany.
Neuroscience. 2018 Aug 21;386:24-40. doi: 10.1016/j.neuroscience.2018.06.019. Epub 2018 Jun 19.
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a fatal motoneuron disorder in children with unknown etiology. The disease is caused by mutations in the IGHMBP2 gene, encoding a Super Family 1 (SF1)-type RNA/DNA helicase. IGHMBP2 is a cytosolic protein that binds to ribosomes and polysomes, suggesting a role in mRNA metabolism. Here we performed morphological and functional analyses of isolated immunoglobulin μ-binding protein 2 (Ighmbp2)-deficient motoneurons to address the question whether the SMARD1 phenotype results from de-regulation of protein biosynthesis. Ighmbp2-deficient motoneurons exhibited only moderate morphological aberrations such as a slight increase of axonal branches. Consistent with the rather mild phenotypic aberrations, RNA sequencing of Ighmbp2-deficient motoneurons revealed only minor transcriptome alterations compared to controls. Likewise, we did not detect any global changes in protein synthesis using pulsed SILAC (Stable Isotope Labeling by Amino acids in Cell culture), FUNCAT (FlUorescent Non-Canonical Amino acid Tagging) and SUnSET (SUrface SEnsing of Translation) approaches. However, we observed reduced β-actin protein levels at the growth cone of Ighmbp2-deficient motoneurons which was accompanied by reduced level of IMP1/ZBP1, a known interactor of β-actin mRNA. Fluorescence Recovery after Photobleaching (FRAP) studies revealed translational down-regulation of an eGFP--β-actin 3'UTR mRNA in growth cones. Local translational regulation of β-actin mRNA was dependent on the 3' UTR but independent of direct Ighmbp2-binding to β-actin mRNA. Taken together, our data indicate that Ighmbp2 deficiency results in local but modest disruption of protein biosynthesis which might partially contribute to the motoneuron defects seen in SMARD1.
1 型脊髓性肌萎缩伴呼吸窘迫症(SMARD1)是一种致命的儿童运动神经元疾病,其病因不明。该疾病由 IGHMBP2 基因突变引起,该基因编码一种超级家族 1(SF1)-型 RNA/DNA 解旋酶。IGHMBP2 是一种胞质蛋白,与核糖体和多核糖体结合,提示其在 mRNA 代谢中发挥作用。在这里,我们对分离的免疫球蛋白 μ 结合蛋白 2(Ighmbp2)缺陷运动神经元进行了形态和功能分析,以解决 SMARD1 表型是否由蛋白质生物合成失调引起的问题。Ighmbp2 缺陷运动神经元仅表现出中度形态异常,如轴突分支略有增加。与相对温和的表型异常一致,与对照相比,Ighmbp2 缺陷运动神经元的 RNA 测序仅显示出轻微的转录组改变。同样,我们使用脉冲 SILAC(细胞培养中的稳定同位素标记通过氨基酸)、FUNCAT(荧光非典型氨基酸标记)和 SUnSET(表面翻译感应)方法均未检测到任何蛋白质合成的全局变化。然而,我们观察到 Ighmbp2 缺陷运动神经元生长锥处的 β-肌动蛋白蛋白水平降低,同时 IMP1/ZBP1 水平降低,IMP1/ZBP1 是 β-肌动蛋白 mRNA 的已知相互作用物。荧光恢复后光漂白(FRAP)研究显示,生长锥中 eGFP-β-肌动蛋白 3'UTR mRNA 的翻译下调。β-肌动蛋白 mRNA 的局部翻译调控依赖于 3'UTR,但不依赖于 Ighmbp2 与 β-肌动蛋白 mRNA 的直接结合。总之,我们的数据表明,Ighmbp2 缺乏导致局部但适度的蛋白质生物合成破坏,这可能部分导致 SMARD1 中观察到的运动神经元缺陷。